These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10940510)

  • 1. Serum alpha-N-acetylgalactosaminidase is associated with diagnosis/prognosis of patients with squamous cell carcinoma of the uterine cervix.
    Reddi AL; Sankaranarayanan K; Arulraj HS; Devaraj N; Devaraj H
    Cancer Lett; 2000 Sep; 158(1):61-4. PubMed ID: 10940510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of serum alpha-N-acetylgalactosaminidase measurement for the assessment of tumour response to radio- and photodynamic therapy.
    Korbelik M; Naraparaju VR; Yamamoto N
    Br J Cancer; 1998 Mar; 77(6):1009-14. PubMed ID: 9528849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic utility of serum alpha-N-acetylgalactosaminidase and immunosuppression resulted from deglycosylation of serum Gc protein in oral cancer patients.
    Yamamoto N; Naraparaju VR; Urade M
    Cancer Res; 1997 Jan; 57(2):295-9. PubMed ID: 9000571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF).
    Yamamoto N; Suyama H; Yamamoto N; Ushijima N
    Int J Cancer; 2008 Jan; 122(2):461-7. PubMed ID: 17935130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF.
    Yamamoto N; Suyama H; Nakazato H; Yamamoto N; Koga Y
    Cancer Immunol Immunother; 2008 Jul; 57(7):1007-16. PubMed ID: 18058096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation.
    Mohamad SB; Nagasawa H; Uto Y; Hori H
    Comp Biochem Physiol A Mol Integr Physiol; 2002 May; 132(1):1-8. PubMed ID: 12062184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the hemagglutinin of influenza virus.
    Yamamoto N; Urade M
    Microbes Infect; 2005 Apr; 7(4):674-81. PubMed ID: 15848273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of α-N-acetylgalactosaminidase (nagalase) concentration in alcohol-dependent individuals without liver disease, during the detoxification therapy.
    Zoga M; Nikou T; Ioannidis A; Tzavellas E; Paparrigopoulos T; Lambrokostopoulos KT; Vasdekis VG; Magana M; Chatzipanagiotou S
    Drug Alcohol Depend; 2017 Jan; 170():147-151. PubMed ID: 27907862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the envelope glycoprotein gp160 of human immunodeficiency virus Type 1.
    Yamamoto N
    AIDS Res Hum Retroviruses; 2006 Mar; 22(3):262-71. PubMed ID: 16545013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of vitamin D-binding protein-derived macrophage activating factor on Ehrlich ascites tumor-bearing mice.
    Koga Y; Naraparaju VR; Yamamoto N
    Proc Soc Exp Biol Med; 1999 Jan; 220(1):20-6. PubMed ID: 9893164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of salivary gland adenocarcinoma cell-derived alpha-N-acetylgalactosaminidase on the bioactivity of macrophage activating factor.
    Matsuura T; Uematsu T; Yamaoka M; Furusawa K
    Int J Oncol; 2004 Mar; 24(3):521-8. PubMed ID: 14767536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deglycosylation of serum vitamin D3-binding protein by alpha-N-acetylgalactosaminidase detected in the plasma of patients with systemic lupus erythematosus.
    Yamamoto N; Naraparaju VR; Moore M; Brent LH
    Clin Immunol Immunopathol; 1997 Mar; 82(3):290-8. PubMed ID: 9073553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF).
    Yamamoto N; Ushijima N; Koga Y
    J Med Virol; 2009 Jan; 81(1):16-26. PubMed ID: 19031451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCC antigen in the serum as an independent prognostic factor in operable squamous cell carcinoma of the cervix.
    Strauss HG; Laban C; Lautenschläger C; Buchmann J; Schneider I; Koelbl H
    Eur J Cancer; 2002 Oct; 38(15):1987-91. PubMed ID: 12376202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF.
    Yamamoto N; Suyama H; Yamamoto N
    Transl Oncol; 2008 Jul; 1(2):65-72. PubMed ID: 18633461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
    Liu CZ; Zeng HX; Zhao JJ; Rong Y; Mo ZL; Li LA; Zhang JQ
    Int J Gynecol Cancer; 2017 Jun; 27(5):994-1000. PubMed ID: 28498239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy.
    Hong JH; Tsai CS; Chang JT; Wang CC; Lai CH; Lee SP; Tseng CJ; Chang TC; Tang SG
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):823-30. PubMed ID: 9652844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GC protein-derived macrophage-activating factor decreases α-
    Thyer L; Ward E; Smith R; Branca JJ; Morucci G; Gulisano M; Noakes D; Eslinger R; Pacini S
    Oncoimmunology; 2013 Aug; 2(8):e25769. PubMed ID: 24179708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is α-N-acetylgalactosaminidase the key to curing cancer? A mini-review and hypothesis.
    Saburi E; Tavakol-Afshari J; Biglari S; Mortazavi Y
    J BUON; 2017; 22(6):1372-1377. PubMed ID: 29332325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.